Assessment of patient tissues with CD163-positive tumor cells correlated with higher tumor grade, invasiveness, radioresistance and poor progression free- and overall survival in melanoma (111), breast (54, 112, 113), CRC (113), renal cell (114), and gastric (115) carcinomas. Here, CD163 is linked to neoplasm.